Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Syed Raza

Syed Raza

Awali Hospital, Bahrain

Title: Use of Risk Assessment Tool to optimise cardiovascular management strategy

Biography

Biography: Syed Raza

Abstract

Introduction: It is neccessary to risk stratify patients  of cardiovascular  diseases  so as to guide and standerdise  management .

Method : We  made  use of QRisk 2 (UK)  to assess  10 year cardiovascular  risk of patients  who presented to the Cardiology clinic. Each patient’s relevant data were  entered  in the  QRisk2  assessment  tool  and  a 10 year risk was worked out. Based on the obtained figure, further management  strategy  was planned  for  that patient.

Analysis and Results: All low risk patients unless contraindicated underwent some kind of stress testing for evidence of reversible ischemia. Decision based of CV risk score to perform CT coronary angiography  when deemed apparopriate  were  utilised for moderate  risk  category.  Majority of high risk patients  were considered for catheter based coronary angiography. Similarly, based on CV risk scoring, Aspirin and Statin therapy were started in 34% and 28% patients respectively. Aspirin and Statin therapy if deemed inappropriate were stopped in 12% and 21% patients respectively.

Conclusion: Simple cardiovascular assessment  tools are readily available  online  that can be downloaded for personal use. Using cardiovascular risk assessment tool simplifies clinical decision making. It helps to  standerdise  treatment  and also guides us to avoid  harmful, inappropriate  and unneccessary  treatment. This  therefore is very suitable  for day to day parctice  and  works best in the interest of patient safety.  Appropriate  use  of  investigations and other resources are used in managing  patients further.